David Tingley
@davidtingley.bsky.social
Reposted by David Tingley
Thanks Misha for the shout-out!
It has been a truly mind-opening journey. WHOLISTIC is one step towards whole-organism neuroscience and a true physiological observatory - with extensions on the way! I am continually amazed by what the data reveals - so much remains to be discovered and mined.
It has been a truly mind-opening journey. WHOLISTIC is one step towards whole-organism neuroscience and a true physiological observatory - with extensions on the way! I am continually amazed by what the data reveals - so much remains to be discovered and mined.
Preprint -
Excited to present WHOLISTIC, which extends the concept of whole-brain functional imaging to the entire body. Pioneering work by incredibly talented Virginia Ruetten @vmsruetten.bsky.social, this platform reveals whole-organism cellular dynamics in vivo.
www.biorxiv.org/content/10.1...
Excited to present WHOLISTIC, which extends the concept of whole-brain functional imaging to the entire body. Pioneering work by incredibly talented Virginia Ruetten @vmsruetten.bsky.social, this platform reveals whole-organism cellular dynamics in vivo.
www.biorxiv.org/content/10.1...
September 8, 2025 at 4:30 PM
Thanks Misha for the shout-out!
It has been a truly mind-opening journey. WHOLISTIC is one step towards whole-organism neuroscience and a true physiological observatory - with extensions on the way! I am continually amazed by what the data reveals - so much remains to be discovered and mined.
It has been a truly mind-opening journey. WHOLISTIC is one step towards whole-organism neuroscience and a true physiological observatory - with extensions on the way! I am continually amazed by what the data reveals - so much remains to be discovered and mined.
Some really cool work we've been doing @oliolabs.bsky.social. New science opens the door to better medicines.
Sex differences in GLP-1 signaling across species https://www.biorxiv.org/content/10.1101/2025.03.17.643822v1
March 19, 2025 at 10:16 PM
Some really cool work we've been doing @oliolabs.bsky.social. New science opens the door to better medicines.
Reposted by David Tingley
In this week's edition of our healthcare newsletter InnovationRx, @amyfeldman7.bsky.social & I look at:
💉 The Trump Administration's mixed messaging on vaccines.
🩺 Sex differences in side effects of GLP-1 medications
🤖 Using AI to predict epidemics
And more!
www.forbes.com/sites/innova...
💉 The Trump Administration's mixed messaging on vaccines.
🩺 Sex differences in side effects of GLP-1 medications
🤖 Using AI to predict epidemics
And more!
www.forbes.com/sites/innova...
InnovationRx: Trump Administration Sends Mixed Messages On Vaccines
In this week’s edition of InnovationRx, we look at the policy uncertainty around vaccines, sex differences in GLP-1 drug side effects, the challenges of using AI to predict epidemics and more.
www.forbes.com
March 19, 2025 at 4:39 PM
In this week's edition of our healthcare newsletter InnovationRx, @amyfeldman7.bsky.social & I look at:
💉 The Trump Administration's mixed messaging on vaccines.
🩺 Sex differences in side effects of GLP-1 medications
🤖 Using AI to predict epidemics
And more!
www.forbes.com/sites/innova...
💉 The Trump Administration's mixed messaging on vaccines.
🩺 Sex differences in side effects of GLP-1 medications
🤖 Using AI to predict epidemics
And more!
www.forbes.com/sites/innova...
Some really cool work we've been doing @oliolabs.bsky.social. New science opens the door to better medicines.
Sex differences in GLP-1 signaling across species https://www.biorxiv.org/content/10.1101/2025.03.17.643822v1
March 19, 2025 at 10:15 PM
Some really cool work we've been doing @oliolabs.bsky.social. New science opens the door to better medicines.
Reposted by David Tingley
Check out what we're working on at Olio Labs!
70% of patients taking GLP-1's (like Ozempic) are women, but they experience >2x side effect rates than men.
What is driving this difference?
We combine human EMR data, mouse & rat behavior, and scRNAseq to figure it out:
70% of patients taking GLP-1's (like Ozempic) are women, but they experience >2x side effect rates than men.
What is driving this difference?
We combine human EMR data, mouse & rat behavior, and scRNAseq to figure it out:
March 19, 2025 at 7:27 PM
Check out what we're working on at Olio Labs!
70% of patients taking GLP-1's (like Ozempic) are women, but they experience >2x side effect rates than men.
What is driving this difference?
We combine human EMR data, mouse & rat behavior, and scRNAseq to figure it out:
70% of patients taking GLP-1's (like Ozempic) are women, but they experience >2x side effect rates than men.
What is driving this difference?
We combine human EMR data, mouse & rat behavior, and scRNAseq to figure it out:
Reposted by David Tingley
This guy.
Imagine a world where nations help instead of trying to occupy each other.
We would all be residents of our tiny Earth in this endless universe.
There would be no foreigners anymore.
Think of the joy and belonging that would spread everywhere.
🌟
(Share stories that help people find commonality)
We would all be residents of our tiny Earth in this endless universe.
There would be no foreigners anymore.
Think of the joy and belonging that would spread everywhere.
🌟
(Share stories that help people find commonality)
March 15, 2025 at 7:14 PM
This guy.
Congrats to Xuefeng and the authors on a great paper.
academic.oup.com/sleep/advanc...
Sometimes things do line up between species
academic.oup.com/sleep/advanc...
Sometimes things do line up between species
February 28, 2025 at 4:58 AM
Congrats to Xuefeng and the authors on a great paper.
academic.oup.com/sleep/advanc...
Sometimes things do line up between species
academic.oup.com/sleep/advanc...
Sometimes things do line up between species